BioLine RX stock price target raised to $10 from $5 at Maxim Group

1 BUSINESS

Business News - Opportunities - Reviews

 

 

BioLine RX Ltd. ADR

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which focuses on oncology. Its oncology programs include Motaxafortide (BL-8040), which is therapy platform used in the treatment of pancreatic cancer; and AGI-134 is a immunotherapy treatment used fro multiple solid tumors. The company was founded in April 2003 and is headquartered in Modi’in, Israel.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply